Diabetes: precision approach will improve outcomes, says research directorBMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l186 (Published 11 January 2019) Cite this as: BMJ 2019;364:l186
- Susan Mayor
A precision approach that is based on greater understanding of different subtypes of diabetes and responses to treatment is needed to improve outcomes in diabetes, the research director of Diabetes UK told a meeting this week.
“Precision medicine is talked about a lot in relation to cancer. But we need to think about precision medicine from a diabetes perspective as a real potential for the future,” said Elizabeth Robertson.
She added, “Diabetes is complex so needs a personalised approach to prevention, diagnosis, treatment, and care. There is still a lot we don’t understand about diabetes. The more research we do into diabetes the more we understand that it’s an individual condition.”
She explained that evidence was now emerging that diabetes was very heterogeneous. A recent Swedish study classified adult onset diabetes into five different groups.1 “One of these …